AEA Investors



Fred joined AEA in 2020 as an Operating Partner focusing on investments in the Value-Added Industrials sector.

Prior to AEA, Fred served as President and CEO of Masonite International, which went public in 2013 under his leadership. Previously, Fred was President of Human Generic Pharmaceuticals and Senior Vice President of Supply Chain at Actavis, a specialty pharmaceutical manufacturer. Fred began his career at Honeywell (previously Allied Signal), where he held progressively senior roles.